MacroGenics, Inc. Forecast, price target & analysts
MacroGenics, Inc. Target price 2025 - Analyst rating & recommendation
MacroGenics, Inc. Classifications & Recommendation:
MacroGenics, Inc. Price Target
| Target Price | $3.06 |
| Price | $1.69 |
| Potential |
81.07%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target MacroGenics, Inc. 2026 .
The average MacroGenics, Inc. target price is $3.06.
This is
81.07%
register free of charge
$8.40
397.04%
register free of charge
$2.02
19.53%
register free of charge
|
|
| A rating was issued by 13 analysts: 7 Analysts recommend MacroGenics, Inc. to buy, 6 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MacroGenics, Inc. stock has an average upside potential 2026 of
81.07%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 149.96 | 37.43 |
| 155.25% | 75.04% | |
| EBITDA Margin | -68.71% | -255.08% |
| 74.55% | 271.23% | |
| Net Margin | -44.66% | -380.00% |
| 189.59% | 750.90% |
9 Analysts have issued a sales forecast MacroGenics, Inc. 2025 . The average MacroGenics, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an MacroGenics, Inc. EBITDA forecast 2025. The average MacroGenics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 MacroGenics, Inc. Analysts have issued a net profit forecast 2025. The average MacroGenics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.07 | -2.25 |
| 613.33% | 110.28% | |
| P/E | negative | |
| EV/Sales | negative |
9 Analysts have issued a MacroGenics, Inc. forecast for earnings per share. The average MacroGenics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
MacroGenics, Inc....
Current MacroGenics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Leerink Partners |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | May 20 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | May 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Aug 15 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
May 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 25 2025 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Nov 07 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 06 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
